Panaich Sidakpal S, Patel Nilay, Arora Shilpkumar, Patel Nileshkumar J, Patel Samir V, Savani Chirag, Singh Vikas, Sonani Rajesh, Deshmukh Abhishek, Cleman Michael, Mangi Abeel, Forrest John K, Badheka Apurva O
Sidakpal S Panaich, Interventional Cardiology, Borgess Medical Center, Kalamazoo, MI 49048, United States.
World J Cardiol. 2016 Apr 26;8(4):302-9. doi: 10.4330/wjc.v8.i4.302.
Hospital volume is regarded amongst many in the medical community as an important quality metric. This is especially true in more complicated and less commonly performed procedures such as structural heart disease interventions. Seminal work on hospital volume relationships was done by Luft et al more than 4 decades ago, when they demonstrated that hospitals performing > 200 surgical procedures a year had 25%-41% lower mortality than those performing fewer procedures. Numerous volume-outcome studies have since been done for varied surgical procedures. An old adage "practice makes perfect" indicating superior operator and institutional experience at higher volume hospitals is believed to primarily contribute to the volume outcome relationship. Compelling evidence from a slew of recent publications has also highlighted the role of hospital volume in predicting superior post-procedural outcomes following structural heart disease interventions. These included transcatheter aortic valve repair, transcatheter mitral valve repair, septal ablation and septal myectomy for hypertrophic obstructive cardiomyopathy, left atrial appendage closure and atrial septal defect/patent foramen ovale closure. This is especially important since these structural heart interventions are relatively complex with evolving technology and a steep learning curve. The benefit was demonstrated both in lower mortality and complications as well as better economics in terms of lower length of stay and hospitalization costs seen at high volume centers. We present an overview of the available literature that underscores the importance of hospital volume in complex structural heart disease interventions.
在医学界,许多人将医院手术量视为一项重要的质量指标。在诸如结构性心脏病干预等更为复杂且开展频率较低的手术中,情况尤其如此。40多年前,卢夫特等人开展了关于医院手术量关系的开创性研究,他们发现,每年实施超过200例外科手术的医院,其死亡率比手术量较少的医院低25% - 41%。此后,针对各种外科手术进行了大量的手术量 - 结果研究。一句古老的格言“熟能生巧”表明,手术量较高的医院中,术者和机构的经验更丰富,这被认为是手术量与结果关系的主要原因。近期大量出版物中的有力证据也凸显了医院手术量在预测结构性心脏病干预后更好的术后结果方面的作用。这些手术包括经导管主动脉瓣修复术、经导管二尖瓣修复术、肥厚性梗阻性心肌病的室间隔消融术和室间隔心肌切除术、左心耳封堵术以及房间隔缺损/卵圆孔未闭封堵术。这一点尤为重要,因为这些结构性心脏病干预相对复杂,技术不断发展,学习曲线较陡。在高手术量中心,较低的死亡率和并发症以及较短的住院时间和住院费用所体现出的更好的经济效益都证明了这种益处。我们对现有文献进行了综述,强调了医院手术量在复杂结构性心脏病干预中的重要性。